The effects of proton pump inhibition on patient‐reported severity of dyspepsia when receiving dual anti‐platelet therapy with clopidogrel and low‐dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 365-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

The FDA Outlook of Events Reporting after Ticagrelor or Clopidogrel in the PLATO Trial: Impact of Sponsor Censoring Dates, Drug Discontinuation, and Withdrawal of Consent

By  

Cardiology, Vol. 120, Iss. 3, 2012-01 ,pp. : 169-171

Karger

Access to resources Recommend Favorite

Triple versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Adding Cilostazol to Aspirin and Clopidogrel?

By  

Cardiology, Vol. 126, Iss. 4, 2013-10 ,pp. : 233-243

Karger

Access to resources Recommend Favorite

Comparison of patient intake of ticagrelor, prasugrel, or clopidogrel on restoring platelet function by donor platelets

By  

TRANSFUSION, Vol. 55, Iss. 6, 2015-06 ,pp. : 1320-1326

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor

By De Servi Stefano   Navarese Eliano Pio   D’Urbano Maurizio   Savonitto Stefano  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2117-2122

Informa Healthcare

Access to resources Recommend Favorite